NEU neuren pharmaceuticals limited

Ann: Phase 3 trial of trofinetide in Rett syndrome commences, page-22

  1. 2,750 Posts.
    lightbulb Created with Sketch. 1051
    WAG that was an uncomfortable reality check that made me go do a little research. In our phase 2 we looked at 82 patients with 12 sites and screening/recruitment did not seem to take that long, a few months from memory.

    In this we have double the number of people to recruit/screen from an eventual 16 sites. You would imagine most previous participants would be keen if they don't have commitments elsewhere and if the original 12 sites are part of the 16 (I didn't check). This should provide a strong base for recruitment you would think (unless they also need to be fully screened again - I have no idea how these things work)

    Maybe someone with a clue like @hottod could comment but 12-18 months seems a ridiculously long time given the phase 2 managed it in much shorter time (albeit with half the patient numbers and shorter commitment required).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.31
Change
0.770(6.14%)
Mkt cap ! $1.655B
Open High Low Value Volume
$12.96 $14.00 $12.91 $19.76M 1.453M

Buyers (Bids)

No. Vol. Price($)
1 3000 $13.30
 

Sellers (Offers)

Price($) Vol. No.
$13.33 3716 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.